Analysis of ribosyl-modified, mixed backbone analogs of a bcl-2/bcl-xL antisense oligonucleotide (Q74179761)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Analysis of ribosyl-modified, mixed backbone analogs of a bcl-2/bcl-xL antisense oligonucleotide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Robert A Olie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Jonathan Hall

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Francois Natt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Rolf A Stahel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Uwe Zangemeister-Wittke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

1576

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

101-109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

cites work

Does antisense exist?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

The therapeutic potential of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Gene inhibition using antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Pharmacology of antisense oligonucleotide inhibitors of protein expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Conformational preorganization, hydration, and nucleic acid duplex stability

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Potent and nontoxic antisense oligonucleotides containing locked nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically-modified DNA:RNA duplexes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Characterization of fully 2'-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Anti-tumor activity of C-raf antisense--correction.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Induction of apoptosis in lung-cancer cells following bcl-xL anti-sense treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Antisense bcl-2 treatment increases programmed cell death in non-small cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Bcl-xl antisense treatment induces apoptosis in breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Molecular mechanisms of antisense drugs: RNase H.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Antisense inhibitory effect: A comparison between 3?-partial and full phosphorothioate antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Antisense therapeutics: is it as simple as complementary base recognition?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Antisense therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Number and distribution of methylphosphonate linkages in oligodeoxynucleotides affect exo- and endonuclease sensitivity and ability to form RNase H substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Bcl-2 family proteins as targets for anticancer drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Targeting tumor cell resistance to apoptosis induction with antisense oligonucleotides: progress and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Backbone modifications in oligonucleotides and peptide nucleic acid systems

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

Hybrid oligonucleotides: synthesis, biophysical properties, stability studies, and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4781%2802%2900300-7

7 January 2021

10.1016/S0167-4781(02)00300-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12031489%20AND%20SRC:MED&resulttype=core&format=json